Zacks Research Raises Humana Q1 2024 Earnings Estimates
July 28, 2023
🌥️Trending News
Humana Inc ($NYSE:HUM). is a leading healthcare services company operating in the United States, offering healthcare coverage to millions of people across the country. Their services include health insurance, pharmacy benefits, dental plans, and more. The new estimates predict that Q1 2024 earnings will be even higher than previously expected. This news has caused investors to take a closer look at Humana Inc.’s stock, which has been steadily trading at a high level for the past few months.
The Zacks Research report also highlighted Humana Inc.’s strong focus on innovation and cost efficiency, which is helping the company to stay competitive in the healthcare space. With the new estimates in mind, investors are increasingly bullish on the company’s future prospects. Humana Inc. is likely to continue to benefit from the growing demand for healthcare services in the United States, making it an attractive investment for many.
Earnings
According to the latest earnings report by Zacks Research, Humana Inc. has had a successful first quarter of 2024. These earnings estimates are sure to give confidence to investors as Humana Inc. continues to transition its business model as well as expand its market share.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Humana Inc. More…
| Total Revenues | Net Income | Net Margin |
| 95.64k | 3.12k | 3.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Humana Inc. More…
| Operations | Investing | Financing |
| 10.97k | -1.65k | -451 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Humana Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 54.78k | 38.14k | 128.39 |
Key Ratios Snapshot
Some of the financial key ratios for Humana Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 12.2% | – | 4.6% |
| FCF Margin | ROE | ROA |
| 10.4% | 17.2% | 5.0% |
Share Price
On Thursday, Humana Inc. (HUM) stock opened at $448.8 and closed at $451.0, up by 0.6% from its prior closing price of $448.2. Live Quote…
Analysis
At GoodWhale, we believe in helping our customers make informed decisions when it comes to investing. That’s why we’ve taken a deep dive into HUMANA INC‘s financials to give you a better idea of what kind of investment it is. In terms of financial and business aspects, our Risk Rating shows that HUMANA INC is a medium-risk investment. However, it’s important to note that our system has detected one risk warning in the balance sheet. To get the full picture, be sure to register on GoodWhale.com and get the latest insights. More…
Peers
In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.
– UnitedHealth Group Inc ($NYSE:UNH)
UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.
UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.
The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.
– Cigna Corp ($NYSE:CI)
Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.
– Oscar Health Inc ($NYSE:OSCR)
Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.
Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.
Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.
Summary
Humana Inc. is an attractive investment opportunity for investors, as analysts at Zacks Research have recently increased their Q1 2024 earnings estimates for the company. This is a positive signal for potential investors, as the upgraded estimates show that Humana is in a financially healthy position and is likely to continue to be successful in the future. Investors should consider conducting further research into Humana and its financials to determine if the company is a good fit for their portfolio. With strong estimates and good industry fundamentals, Humana presents an appealing option for investors.
Related Posts
Recent Posts
